ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $83,156 | -73.3% | 630,945 | +3.3% | 0.00% | -100.0% |
Q2 2023 | $311,376 | -19.3% | 610,545 | -0.3% | 0.00% | 0.0% |
Q1 2023 | $385,777 | +7.6% | 612,345 | +10.9% | 0.00% | 0.0% |
Q4 2022 | $358,363 | -64.2% | 552,229 | -5.2% | 0.00% | -50.0% |
Q3 2022 | $1,002,000 | +39.9% | 582,740 | +0.9% | 0.00% | 0.0% |
Q2 2022 | $716,000 | +58.4% | 577,368 | +1.7% | 0.00% | +100.0% |
Q1 2022 | $452,000 | -0.2% | 567,777 | +36.4% | 0.00% | 0.0% |
Q4 2021 | $453,000 | -44.6% | 416,410 | -7.3% | 0.00% | -50.0% |
Q3 2021 | $817,000 | -9.8% | 448,984 | +30.7% | 0.00% | 0.0% |
Q2 2021 | $906,000 | -27.2% | 343,455 | -0.7% | 0.00% | -33.3% |
Q1 2021 | $1,245,000 | +79.4% | 345,920 | +25.6% | 0.00% | +50.0% |
Q4 2020 | $694,000 | +48.0% | 275,474 | +48.2% | 0.00% | +100.0% |
Q3 2020 | $469,000 | -25.9% | 185,851 | -3.7% | 0.00% | -50.0% |
Q2 2020 | $633,000 | +72.5% | 192,993 | +32.3% | 0.00% | 0.0% |
Q1 2020 | $367,000 | – | 145,861 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |